Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4070547, 10 pages
https://doi.org/10.1155/2017/4070547
Research Article

Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project

1Department of Biostatistics, Virginia Commonwealth University, Richmond, VA 23298, USA
2Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA
3Department of Psychiatry, Virginia Commonwealth University, Richmond, VA 23298, USA
4Department of Emergency Medicine, Harvard University, Boston, MA 02115, USA
5Department of Internal Medicine, Yale University, New Haven, CT 06520, USA
6Department of Pathology, Virginia Commonwealth University, Richmond, VA 23298, USA
7College of Public Health and Human Sciences, Corvallis, OR 97331, USA

Correspondence should be addressed to Donna K. McClish; ude.ucv@hsilccm

Received 7 September 2016; Accepted 8 March 2017; Published 28 March 2017

Academic Editor: Ellen Fung

Copyright © 2017 Donna K. McClish et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Dampier, E. Ely, D. Brodecki, and P. O'Neal, “Home management of pain in sickle cell disease: a daily diary study in children and adolescents,” Journal of Pediatric Hematology/Oncology, vol. 24, no. 8, pp. 643–647, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Dampier, B. Ely, D. Brodecki, and P. O'Neal, “Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports,” Journal of Pain, vol. 3, no. 6, pp. 461–470, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. O. S. Platt, B. D. Thorington, D. J. Brambilla et al., “Pain in sickle cell disease. Rates and risk factors,” The New England Journal of Medicine, vol. 325, no. 1, pp. 11–16, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Panepinto, D. C. Brousseau, C. A. Hillery, and J. P. Scott, “Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease,” Pediatric Blood and Cancer, vol. 44, no. 2, pp. 182–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. W. T. Zempsky, K. A. Loiselle, K. McKay et al., “Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease,” Pediatric Blood and Cancer, vol. 51, no. 2, pp. 265–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. C. Brousseau, P. L. Owens, A. L. Mosso, J. A. Panepinto, and C. A. Steiner, “Acute care utilization and rehospitalizations for sickle cell disease,” The Journal of the American Medical Association, vol. 303, no. 13, pp. 1288–1294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. D. Grosse, S. L. Boulet, D. D. Amendah, and S. O. Oyeku, “Administrative data sets and health services research on hemoglobinopathies. a review of the literature,” American Journal of Preventive Medicine, vol. 38, no. 4, pp. S557–S567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. “Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies,” The Journal of the American Medical Association, vol. 258, no. 9, pp. 1205–1209, 1987.
  9. M. H. Gaston, J. I. Verter, G. Woods et al., “Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial,” New England Journal of Medicine, vol. 314, no. 25, pp. 1593–1599, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. M. T. Lee, S. Piomelli, S. Granger et al., “Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results,” Blood, vol. 108, no. 3, pp. 847–852, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. W. C. Wang, R. E. Ware, S. T. Miller et al., “Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG),” The Lancet, vol. 377, no. 9778, pp. 1663–1672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. H. Steinberg, F. Barton, O. Castro et al., “Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment,” Journal of the American Medical Association, vol. 289, no. 13, pp. 1645–1651, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Charache, M. L. Terrin, R. D. Moore et al., “Effect of hydroxyurea on the frequency of painful crises in Sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia,” The New England Journal of Medicine, vol. 332, no. 20, pp. 1317–1322, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. R. E. Ware, B. R. Davis, W. H. Schultz et al., “Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD with Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial,” The Lancet, vol. 387, no. 10019, pp. 661–670, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Davis, K. C. Schoendorf, P. J. Gergen, and R. M. Moore Jr., “National trends in the mortality of children with sickle cell disease, 1968 through 1992,” American Journal of Public Health, vol. 87, no. 8, pp. 1317–1322, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. R. B. Scott, “Health care priority and sickle cell anemia,” JAMA, vol. 214, no. 4, pp. 731–734, 1970. View at Publisher · View at Google Scholar · View at Scopus
  17. O. S. Platt, D. J. Brambilla, W. F. Rosse et al., “Mortality in sickle cell disease. Life expectancy and risk factors for early death,” New England Journal of Medicine, vol. 330, no. 23, pp. 1639–1644, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Lanzkron, C. Patrick Carroll, and C. Haywood Jr., “Mortality rates and age at death from sickle cell disease: U.S., 1979–2005,” Public Health Reports, vol. 128, no. 2, pp. 110–116, 2013. View at Google Scholar · View at Scopus
  19. D. S. Darbari, P. Kple-Faget, J. Kwagyan, S. Rana, V. R. Gordeuk, and O. Castro, “Circumstances of death in adult sickle cell disease patients,” American Journal of Hematology, vol. 81, no. 11, pp. 858–863, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. S. Darbari, Z. Wang, M. Kwak et al., “Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study,” PLoS ONE, vol. 8, no. 11, Article ID e79923, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. B. P. Yawn, G. R. Buchanan, A. N. Afenyi-Annan et al., “Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members,” JAMA, vol. 312, no. 10, pp. 1033–1048, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Adams-Graves and L. Bronte-Jordan, “Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to care, social issues, and adherence,” Expert Review of Hematology, vol. 9, no. 6, pp. 541–552, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Dampier, P. LeBeau, S. Rhee et al., “Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium,” American Journal of Hematology, vol. 86, no. 2, pp. 203–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Treadwell, J. Telfair, R. W. Gibson, S. Johnson, and I. Osunkwo, “Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research,” American Journal of Hematology, vol. 86, no. 1, pp. 116–120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Treadwell, S. Johnson, I. Sisler et al., “Self-efficacy and readiness for transition from pediatric to adult care in sickle cell disease,” International Journal of Adolescent Medicine and Health, vol. 28, no. 4, pp. 381–388, 2016. View at Publisher · View at Google Scholar
  26. M. Treadwell, S. Johnson, I. Sisler et al., “Development of a sickle cell disease readiness for transition assessment,” International Journal of Adolescent Medicine and Health, vol. 28, no. 2, pp. 193–201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. DeBaun and J. Telfair, “Transition and sickle cell disease,” Pediatrics, vol. 130, no. 5, pp. 926–935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. N. B. Stollon, C. W. Paine, M. S. Lucas et al., “Transitioning adolescents and young adults with sickle cell disease from pediatric to adult health care: provider perspectives,” Journal of Pediatric Hematology/Oncology, vol. 37, no. 8, pp. 577–583, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. B. G. Hemker, D. C. Brousseau, K. Yan, R. G. Hoffmann, and J. A. Panepinto, “When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department,” American Journal of Hematology, vol. 86, no. 10, pp. 863–865, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. K. Dickerson, J. Klima, M. M. Rhodes, and S. H. O'Brien, “Young adults with SCD in US children's hospitals: are they different from adolescents?” Pediatric Blood and Cancer, vol. 58, no. 5, pp. 741–745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Blinder, M. S. Duh, M. Sasane, A. Trahey, C. Paley, and F. Vekeman, “Age-related emergency department reliance in patients with sickle cell disease,” Journal of Emergency Medicine, vol. 49, no. 4, pp. 513–522.e1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. Frost, R. K. Cherry, S. O. Oyeku et al., “Improving sickle cell transitions of care through health information technology,” American Journal of Preventive Medicine, vol. 51, supplement 1, pp. S17–S23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. A. E. Sobota, E. Umeh, and J. W. Mack, “Young adult perspectives on a successful transition from pediatric to adult care in sickle cell disease,” Journal of Hematology Research, vol. 2, no. 1, pp. 17–24, 2015. View at Publisher · View at Google Scholar
  34. L. E. Crosby, C. T. Quinn, and K. A. Kalinyak, “A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care,” Advances in Therapy, vol. 32, no. 4, pp. 293–305, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Labore, B. Mawn, J. Dixon, and B. Andemariam, “Exploring transition to self-management within the culture of sickle cell disease,” Journal of Transcultural Nursing, vol. 28, no. 1, pp. 70–78, 2017. View at Publisher · View at Google Scholar
  36. S. S. Mulchan, J. M. Valenzuela, L. E. Crosby, and C. Diaz Pow Sang, “Applicability of the SMART model of transition readiness for sickle-cell disease,” Journal of Pediatric Psychology, vol. 41, no. 5, pp. 543–554, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Bryant, J. S. Porter, and A. Sobota, “APHON/ASPHO policy statement for the transition of patients with sickle cell disease from pediatric to adult health care,” Journal of Pediatric Oncology Nursing, vol. 32, no. 6, pp. 355–359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. K. M. Gil, M. R. Abrams, G. Phillips, and F. J. Keefe, “Sickle cell disease pain: relation of coping strategies to adjustment,” Journal of Consulting and Clinical Psychology, vol. 57, no. 6, pp. 725–731, 1989. View at Publisher · View at Google Scholar · View at Scopus
  39. F. L. Reese and W. R. Smith, “Psychosocial determinants of health care utilization in sickle cell disease patients,” Annals of Behavioral Medicine, vol. 19, no. 2, pp. 171–178, 1997. View at Publisher · View at Google Scholar
  40. W. R. Smith, V. E. Bovbjerg, L. T. Penberthy et al., “Understanding pain and improving management of sickle cell disease: The PiSCES study,” Journal of the National Medical Association, vol. 97, no. 2, pp. 183–193, 2005. View at Google Scholar · View at Scopus
  41. W. R. Smith, L. T. Penberthy, V. E. Bovbjerg et al., “Daily assessment of pain in adults with sickle cell disease,” Annals of Internal Medicine, vol. 148, no. 2, pp. 94–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. K. Rosenstiel and F. J. Keefe, “The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment,” Pain, vol. 17, no. 1, pp. 33–44, 1983. View at Publisher · View at Google Scholar · View at Scopus
  43. K. A. Anie, A. Steptoe, and D. H. Bevan, “Sickle cell disease: pain, coping and quality of life in a study of adults in the UK,” British Journal of Health Psychology, vol. 7, no. 3, pp. 331–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. J. E. Ware and C. D. Sherbourne, “The MOS 36-item short-form health survey (Sf-36). I. conceptual framework and item selection,” Medical Care, vol. 30, no. 6, pp. 473–483, 1992. View at Publisher · View at Google Scholar · View at Scopus
  45. A. L. Stewart, R. D. Hays, and J. E. Ware Jr., “The MOS short-form general health survey. Reliability and validity in a patient population,” Medical Care, vol. 26, no. 7, pp. 724–735, 1988. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Wittink, D. C. Turk, D. B. Carr, A. Sukiennik, and W. Rogers, “Comparison of the redundancy, reliability, and responsiveness to change among SF-36, Oswestry disability index, and multidimensional pain inventory,” Clinical Journal of Pain, vol. 20, no. 3, pp. 133–142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. D. K. McClish, L. T. Penberthy, V. E. Bovbjerg et al., “Health related quality of life in sickle cell patients: the PiSCES project,” Health and Quality of Life Outcomes, vol. 3, article 50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. S. S. Kazarian and S. B. McCabe, “Dimensions of social support in the MSPSS: factorial structure, reliability, and theoretical implications,” Journal of Community Psychology, vol. 19, no. 2, pp. 150–160, 1991. View at Google Scholar · View at Scopus
  49. N. W. Dahlem, G. D. Zimet, and R. R. Walker, “The multidimensional scale of perceived social support: a confirmation study,” Journal of Clinical Psychology, vol. 47, no. 6, pp. 756–761, 1991. View at Publisher · View at Google Scholar · View at Scopus
  50. R. L. Spitzer, K. Kroenke, and J. B. W. Williams, “Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study,” Journal of the American Medical Association, vol. 282, no. 18, pp. 1737–1744, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. J. L. Levenson, D. K. McClish, B. A. Dahman et al., “Depression and anxiety in adults with sickle cell disease: the PiSCES project,” Psychosomatic Medicine, vol. 70, no. 2, pp. 192–196, 2008. View at Google Scholar
  52. J. L. Levenson, D. K. McClish, B. A. Dahman et al., “Alcohol abuse in sickle cell disease: The Pisces project,” American Journal on Addictions, vol. 16, no. 5, pp. 383–388, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Kroenke, R. L. Spitzer, J. B. W. Williams, and B. Löwe, “The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review,” General Hospital Psychiatry, vol. 32, no. 4, pp. 345–359, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Sogutlu, J. L. Levenson, D. K. McClish, S. D. Rosef, and W. R. Smith, “Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES Project,” Psychosomatics, vol. 52, no. 3, pp. 272–279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Charache, M. L. Terrin, R. D. Moore et al., “Design of the multicenter study of hydroxyurea in sickle cell anemia,” Controlled Clinical Trials, vol. 16, no. 6, pp. 432–446, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. D. K. McClish, W. R. Smith, B. A. Dahman et al., “Pain site frequency and location in sickle cell disease: The PiSCES project,” Pain, vol. 145, no. 1-2, pp. 246–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. E. L. Kroner, R. G. Hoffmann, and D. C. Brousseau, “Emergency department reliance: a discriminatory measure of frequent emergency department users,” Pediatrics, vol. 125, no. 1, pp. 133–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. K. A. Sanders, S. M. Labott, R. Molokie, S. R. Shelby, and J. Desimone, “Pain, coping and health care utilization in younger and older adults with sickle cell disease,” Journal of Health Psychology, vol. 15, no. 1, pp. 131–137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. E. Ahmed, A. S. Alaskar, D. K. McClish et al., “SCD in Saudi children, teens and adults: a study in health related quality of life,” Journal of Blood Disorders, vol. 3, no. 1, article 1036, 2016. View at Google Scholar
  60. T. D. H. McKerrell, H. W. Cohen, and H. H. Billett, “The older sickle cell patient,” American Journal of Hematology, vol. 76, no. 2, pp. 101–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. V. D. A. Citero, J. L. Levenson, D. K. McClish et al., “The role of catastrophizing in sickle cell disease: the PiSCES project,” Pain, vol. 133, no. 1–3, pp. 39–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. D. K. McClish, J. L. Levenson, L. T. Penberthy et al., “Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES project,” Journal of Women's Health, vol. 15, no. 2, pp. 146–154, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Dampier, S. Lieff, P. LeBeau et al., “Health-related quality of life in children with sickle cell disease: a report from the comprehensive sickle cell centers clinical trial consortium,” Pediatric Blood and Cancer, vol. 55, no. 3, pp. 485–494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. K. Ballas, F. B. Barton, M. A. Waclawiw et al., “Hydroxyurea and sickle cell anemia: effect on quality of life,” Health and Quality of Life Outcomes, vol. 4, article 59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. S. M. Bediako, S. Lanzkron, M. Diener-West, G. Onojobi, M. C. Beach, and C. Haywood, “The measure of sickle cell stigma: initial findings from the Improving Patient Outcomes through Respect and Trust Study,” Journal of Health Psychology, vol. 21, no. 5, pp. 808–820, 2014. View at Publisher · View at Google Scholar · View at Scopus